{"abdominal distension": 2.13, "adenocarcinoma pancreas": 23.39, "amylase increased": 4.48, "ankle fracture": 2.45, "blood glucose abnormal": 7.3, "blood glucose decreased": 9.88, "blood glucose fluctuation": 8.3, "blood glucose increased": 8.91, "blood triglycerides increased": 3.16, "body height decreased": 13.44, "carpal tunnel syndrome": 3.97, "cataract": 4.01, "cellulitis": 2.44, "cholelithiasis": 5.45, "circumstance or information capable of leading to medication error": 27.51, "colon cancer": 2.29, "coronary artery occlusion": 7.33, "decreased appetite": 2.33, "dehydration": 2.79, "device defective": 28.65, "device delivery system issue": 36.89, "device difficult to use": 8.78, "device failure": 3.23, "device issue": 37.51, "device leakage": 136.63, "device malfunction": 35.88, "device occlusion": 9.45, "device use issue": 20.8, "diabetes mellitus inadequate control": 5.87, "diabetic ketoacidosis": 2.6, "diabetic neuropathy": 5.81, "drug delivery system issue": 43.56, "drug delivery system malfunction": 9.48, "drug dose omission by device": 24.68, "dyspepsia": 2.36, "eructation": 10.21, "flatulence": 2.03, "gallbladder disorder": 3.97, "gastroenteritis viral": 3.85, "gastrooesophageal reflux disease": 2.16, "glycosylated haemoglobin increased": 23.07, "hepatic steatosis": 2.29, "hernia": 4.32, "hiccups": 2.71, "hyperlipidaemia": 2.52, "hypophagia": 3.92, "impaired gastric emptying": 13.32, "incorrect dose administered": 6.91, "incorrect dose administered by device": 61.5, "increased appetite": 4.35, "injection site abscess": 24.4, "injection site bruising": 16.39, "injection site cellulitis": 27.35, "injection site discharge": 47.91, "injection site discolouration": 14.72, "injection site discomfort": 4.22, "injection site erythema": 2.47, "injection site extravasation": 70.59, "injection site haemorrhage": 81.91, "injection site induration": 7.83, "injection site infection": 24.77, "injection site injury": 38.37, "injection site mass": 73.02, "injection site nodule": 336.59, "injection site pain": 2.85, "injection site pruritus": 9.48, "injection site rash": 6.41, "injection site reaction": 2.2, "injection site scar": 34.51, "injection site urticaria": 14.92, "injury associated with device": 6.0, "intentional device misuse": 85.66, "intentional product misuse": 6.52, "limb injury": 2.12, "lipase increased": 9.83, "localised infection": 3.75, "mass": 3.89, "memory impairment": 2.19, "metastases to liver": 2.55, "myocardial infarction": 2.01, "needle issue": 43.27, "nephrolithiasis": 3.01, "nodule": 7.39, "obesity": 3.77, "pancreatic carcinoma": 4.46, "pancreatic carcinoma metastatic": 19.01, "pancreatic disorder": 8.21, "pancreatitis": 17.29, "pancreatitis acute": 8.36, "product dose omission issue": 6.73, "product packaging quantity issue": 34.82, "product quality issue": 12.28, "product solubility abnormal": 14.97, "product use issue": 2.18, "skin mass": 14.67, "stress": 2.13, "therapy cessation": 4.28, "thyroid cancer": 2.3, "thyroid mass": 13.7, "type 2 diabetes mellitus": 6.85, "weight decreased": 8.36, "weight fluctuation": 7.87, "weight increased": 2.07, "wrong technique in device usage process": 56.43, "wrong technique in product usage process": 3.4}